Lee Grimes Lab

@AbdelWahablab @CD_AACR This is very interesting. Congratulations.

Excited to announce a new paper out now in @CD_AACR on a unique CAR T cell platform that eliminates AML and B-ALL without harming vital endogenous immune cells or other normal human tissues: pubmed.ncbi.nlm.nih.gov/42059863/

MYELOID2026 registration is now closed. We are preparing to welcome the myeloid peeps to Cincinnati! myeloidmeeting.org

MYELOID2026 registration ends April 30th at 5:00 PM.

MYELOID2026 agenda and menus are up. myeloidmeeting.org

@CterminiPhD that is why I hold the myeloid workshop here in Cincinnati every two years. Its a vibe reset.

Feeling the pressure like never before… I know I’m gonna find a path forward but damn, I am stressed. Sending vibes to all who are struggling through these challenging circumstances 😔

Step into the science! ASH Scientific Committees are looking for members to guide the Annual Meeting program, highlight novel research, and advance interdisciplinary discoveries in hematology. Nominate yourself or a colleague: ow.ly/JfUq50YCmHF #Hematology

ASH strongly opposes the Administration’s proposed 12.3% cut to NIH. These reductions would devastate hematology research, harm patients, & undermine U.S. leadership in medical innovation. 🔗 ow.ly/KXfe50YCXnm #Fight4Hematology #ASHinaFlash

@UofUHematology @UofUHealth amazing. Smart move for the Utah Hematology peeps.

Welcome Ulrich G. Steidl, MD, PhD to @UofUHealth as Adjunct Professor of Medicine via SAFEP! An internationally recognized leader in myeloid malignancies, stem cell biology & translational science bringing mentorship, & collaboration to the Division of Hematology

End of Continuous Submission. Now: The only pre-authorized reason for a late submission is if any PD/PI named on the application participates in an NIH peer review study section or special emphasis panel within four calendar weeks before or after the grant submission due date. grants.nih.gov/grants/guide/n…

@MilsomMick youtu.be/-1YjmXSyHa8?si…

MYELOID2026 Get ready to take a Fantastic Voyage. Agenda coming soon.

Last chance to apply for the ASH Award for Research Careers in Hematology (ARCH). The successor to the ASH Bridge Grant, ARCH provides $150k to support research that advances the care of patients with blood disorders. Apply by March 31: ow.ly/HqeF50Ym10j #Fight4Hematology

Boldly Standing Up for Science. With science under political attack and federal funding threatened, ASH stepped up to #Fight4Hematology as never before. The 2025 Annual Report has the full story. 🔗 ow.ly/cqsV50YvOof #ResearchSavesLives

MYELOID2026 Time to figure out the agenda and happy to be joined by @lindemilesphd

News for marrow failure researchers. The DOD program is back! cdmrp.health.mil/pubs/press/202…

ASH ARCH (the new Bridge award applicants have been asking for clarification on the "qualitative statement describing risk status". This is a one‑page opportunity for the applicant to describe any circumstances that place their ongoing research program or career trajectory at risk. Examples may include: Funding that has been restricted, reduced, exhausted, or disallowed based on their research focus; Resources or support that are expected to run out in the near term; Institutional, departmental, or structural changes that may limit their ability to secure or maintain support; or Any other factors that could meaningfully affect the stability or sustainability of their research. This section is intentionally flexible — applicants may frame it in whatever way best reflects the risks they consider most relevant

Real funding numbers at NIH for 2025. report.nih.gov/nihdatabook/re…

We are proud to share that Takanori Takebe, MD, PhD, has been named to the 2026 @TIME 100 Health List of the World’s Most Influential Leaders in Health — becoming the first scientist from Cincinnati Children’s to receive this honor. Learn more: ow.ly/zAes50YcR5F @TakebeLab

Is your funding for hematology research "Between a rock and a hard place" #fightforhematology funds from ASH members and fans now provide a new program: A R C H hematology.org/awards/career-… NOTE: Are you doing well? .....your donations go 100% to lab support in the ARCH program.